OBJECTIVES: Risk stratification in cardiac surgery is uniquely detailed, led latterly by the EuroSCORE and the Society of Thoracic Surgeons (STS) risk calculators. The recently published EuroSCORE II (ES2) algorithms update estimated mortality in a broad spectrum of cardiac procedures. The 2008 STS tool, in comparison, predicts multiple outcomes for specific procedures. We sought to identify and compare the external validity of both contemporaneous tools in our population.
INTRODUCTION
Twelve years ago, Geissler et al. [1] published a comparison of six contemporaneous cardiac surgical risk scores, concluding at the time that the then-new 'Euro score' [sic] yielded the best predictive value for mortality. In the intervening decade, two risk calculators have come to predominate: The Society of Thoracic Surgeons (STS) Risk Score in North America and the EuroSCORE in Europe. The former had not been developed at the time of Geissler's review, while the EuroSCORE risk calculator [2] has continued to demonstrate itself as a well-established and validated tool [3, 4] . Despite evidence that the EuroSCORE model retained excellent discrimination over more than a decade, EuroSCORE was renewed earlier this year with modifications, based on logistic regression analyses of 23 000 patients in 150 hospitals in 43 countries [5] . EuroSCORE II retains the parsimonious approach of its predecessor, with 18 variables making up the risk score, demonstrating the authors' priority of 'clinical usability' when developing the score [6] .
The Society of Thoracic Surgeons Risk Score was most recently updated in 2008 [7] [8] [9] [10] from a multicentre database of over 100 000 index procedures in the United States. Using 67 demographic and operative parameters, the STS Risk Tool calculates predicted mortality for coronary artery bypass grafting, valve procedures and combined cases. In addition, the extensive calculator estimates a number of other comorbidities including renal failure, cerebrovascular accident, deep sternal wound infections and risk of prolonged ITU stay.
Since publication, the EuroSCORE II has been validated in large, European, multicentre cohorts of both historical patients and those operated on since the data used to design the calculator was collected. Barili et al. [11] found that the performance of the tool was 'more than satisfactory', and well calibrated for a large proportion of patients, although in the higher tertiles of risk it did not improve on the original additive or logistic EuroSCORE. Grant et al. [12] described it as an 'acceptable generic cardiac surgery risk model', but found that it was poorly calibrated for the highest and lowest risk patients.
To date, a direct comparison of the two most recent and commonly used risk calculators worldwide has not been made. We sought to establish the validity and predictive powers of the EuroSCORE II and the 2008 Society of Thoracic Surgeons risk scores in a large cohort of patients undergoing a variety of cardiac surgical procedures.
MATERIALS AND METHODS
The study was approved as an audit by the local ethics committee and patient consent was waived. Demographic information for the whole population is summarized in Table 1 , and included all risk factors described by the Society of Thoracic Surgeons 2008 risk score with the exception of ethnic origin, which was not routinely collected. All factors for calculating EuroSCORE II risks were available, with the exception of poor mobility due to musculoskeletal or neurological dysfunction.
The various algorithms for calculating risk were applied to these records, to calculate EuroSCORE II and STS 2008 risk scores for each patient. For the subgroup not applicable to STS risk scoring, we applied the same logistic regression functions for each parameter from the index operation (valve, graft or valve and graft). Where data were missing, we assumed a null value for categorical variables, assuming a disease state was absent. Where a continuous variable was missing, we applied the algorithm for imputed missing data dictated by the STS calculator.
Definitions
Where differences existed in the standard units of measurement between the USA and the UK (e.g. serum creatinine), appropriate conversions were applied for calculations, but the data presented here are in British units. Quantitative measurements that referred to qualitative descriptors in the STS score (i.e. chronic lung disease, which is stratified as mild, moderate or severe in the STS risk variables but was measured at our centre as forced expiratory volume in 1 s) were graded according to published criteria [13] .
Statistical analysis
Statistical tests were performed using JMP 9.0.2 for Mac (SAS Institute, Inc., Cary, NC, USA) and R software (R Core Team, Vienna, Austria) [14] . The receiver-operating curve (ROC) was employed to test the discrimination of each model using the area under the receiver operator curve (AUROC) or C-statistic. The calibration of the model was interrogated using the Hosmer-Lemeshow (H-L) test for goodness of fit using a standard decile format. Comparison between ROC curves was performed using DeLong's method [15, 16] .
RESULTS

All procedures
For all 15 497 procedures undertaken at our institution, the overall in-hospital mortality was 547 patients, or 3.5% (95% CI: 3.3-3.8). The EuroSCORE II Score ranged from 0.48 to 74.80% (mean 2.53, 95% CI: 2.48-2.59). The AUROC was 0.818, with an H-L goodness-of-fit statistic P value of <0.001.The STS Risk Score ranged from 0.20 to 72.78% (mean 2.39, 95% CI: 2.34-2.45). The AUROC for risk of perioperative death was 0.805, with an H-L goodness-of-fit statistic P < 0.001. Comparison between the two scoring systems by DeLong's method showed no significant difference (P = 0.343).
Society of Thoracic Surgeons-applicable procedure
For 14 432 patients in whom the STS score could be applied, the overall mortality in hospital was 447 or 3.1% (95% CI: 2.8-3.4). 
Procedures not applicable to Society of Thoracic Surgeons scoring
One thousand and sixty-five patients underwent operations for which the 2008 STS Risk Calculator does not claim to stratify. The mortality in this group was 9.3% (95% CI: 7.8-11.3). The EuroSCORE II Score ranged from 0.48 to 52.1% (mean 3. 
COMMENT
The discrimination of both the EuroSCORE II and STS 2008 risk stratification calculators in our institution was moderate to good, with AUROC values between 0.77 and 0.82 for all patients, including those not normally stratified by the STS score. The calibration of both tools was, however, inferred to be consistently poor with H-L goodness-of-fit tests being statistically significant in all cases (P < 0.001). As Sergeant et al. noted, however, a significant H-L statistic does not necessarily mean that a model is not well calibrated [17] and early papers citing the superiority of the original EuroSCORE over other risk stratification tools did not employ goodness-of-fit tests [3] . Indeed, even in the original publication of the EuroSCORE II, the validation of the model demonstrated a goodness of fit that was only just non-significant at P = 0.0505 when applied to the whole dataset. This was later shown to be P = 0.09316 in the validation subgroup [18] .
The H-L performs a χ 2 test comparing the observed and expected outcomes for deciles of each test group (Table 2) . Any divergence of the observed and expected outcomes leads to a statistically significant difference, whether or not the divergence is consistent or at a single averaged decile. At higher predicted mortalities, both models tend to under-predict (Figs 3 and 4) . The H-L test may, however, be poorly equipped to deal with the weighted, non-parametric distribution of risks of a large test population. Decile subgrouping of several thousand patients with narrow error at the left end of the distribution leads to averaging errors in the highest risk group. This is illustrated in the probability intervals of the decile groups for the H-L test ( Table 2 ). The first nine deciles, i.e. 90% of the patients, have a predicted risk of <5%. The final decile represents 1500 of the highest risk patients, ranging from 3.3 to 74.8%, where around a third of these were predicted to be at risk of >10%, and only 5 patients had a predicted mortality of >50%. When the distribution is over 100 subgroups instead, however, (i.e. percentiles ADULT CARDIAC instead of deciles) these averaging errors are minimized, and the observed and expected curves for both risk calculators show more coherence (Figs 5 and 6 ). Divergence still occurs, but begins at 10-15% risk rather than 2-3% as comparisons are made of patients at similar risk strata. At this risk level, the range of expected mortality increases due to a larger variability of comorbidities in the risk groups and smaller numbers. The strength of the calculators is presumably also lower due to the relatively lower number of high-risk patients in the modelling populations. The conclusions drawn from the results of the H-L tests must, therefore, be guarded and a clear distinction must be made between the ability of a model to discriminate between highand low-risk patients, which both tools do effectively, and the failure of a model to calibrate through all risk stratifications. The observed vs expected mortality graphs show that both calculators distinguish well between patients at different risk, even if the precise quantification of that risk is imperfect. Much has already been written about the use of the H-L tool in prediction validation [6, 12, 17, [19] [20] [21] [22] , and we retain our own reservations about the statistical methods employed to demonstrate 'poor calibration' of the calculators. This view was recently corroborated by one of the original authors of the H-L test with statistical proof that the decile-based test is not appropriate for large populations [23] .
The STS risk score for morbidity is not frequently utilized in the British setting due to the popularity the original additive EuroSCORE derived from it's 'back of the envelope' simplicity. The logistic EuroSCORE maintained the interest of early adopters as it utilized the same, limited parameters, and both the additive and logistic EuroSCORE I were easy and quick to calculate validate and allow accurate risk prediction. With EuroSCORE II, the model calibration continues to improve with a parsimonious array of factors that maintain the original calculator's usability. Critics of both EuroSCORE and STS calculators point out that certain risk factors are unaccounted for and that the interaction between risk factors is not always represented. STS does so with a number of select interactions.
Our study suggests that careful choice of a limited number of independent risk factors can provide as effective a risk model as one that includes calculations for multiple interactions. Until the advent of more advanced, accurate and instantly available prediction models, the assessment between two equally discriminating tools falls in favour of the one that is easier to use.
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